DNA repair inhibitors

Bibliography

• WOOD RD: DNA repair in eukariotes. Ann. Rev. Bio-chem. (1996) 65:135–167.
   PubMed Web of Science ®Google Scholar
• CHANEY SG, SANCAR A: DNA repair: enzymatic mecha-nisms and relevance to drug response. J. Nail Cancer Inst. (1996) 88:1346–1360.
   PubMedGoogle Scholar
• •A comprehensive review on DNA adducts and their repair.
   Google Scholar
• NAEGELI H: Mechanisms of DNA damage recognition in mammalian nucleotide excision repair. FASEB J. (1995) 9:1043–1050.
   PubMed Web of Science ®Google Scholar
• SINGER B, HANG B: What structural features determine repair enzyme specificity and mechanism in chemi-cally modified DNA? Chem. Res. Toxicol (1997) 10:713–732.
   PubMedGoogle Scholar
• SANCAR A: DNA excision repair. Ann. Rev. Biochem. (1996) 65:43–81.
   PubMed Web of Science ®Google Scholar
• KROKAN HE, STANDAL R, SLUPPHAUG G: DNA glycosy-lases in the base excision repair of DNA. Biochem. J. (1997) 325:1–16.
   PubMed Web of Science ®Google Scholar
• •A review on specific enzymes implicated in modified bases removal.
   Google Scholar
• MITRA S, HAZRA TK, ROY R et al.: Complexities of DNA base excision repair in mammalian cells. Mol. Cells (1997) 7:305–312.
   PubMed Web of Science ®Google Scholar
• VERDINE GL, BRUNER SD: How do DNA repair proteins locate damaged bases in the genome? Chem. Biol. (1997) 4:329–334.
   Google Scholar
• WOOD RD, SHIVJI MKK: Which DNA polymerases are used for DNA repair in eukariotes? Carcinogenesis (1997) 18:605–610.
   PubMedGoogle Scholar
• JEGGO PA: DNA repair: PARP - another guardian angel? Curr. Biol. (1998) 8:R49–R51.
   Google Scholar
• •A short discussion on the possible roles of PARP in DNA repair.
   Google Scholar
• CALDECOTT KW, AOUFOUCHI S, JOHNSON P, SHALL S: XRCC1 polypeptide interacts with DNA polymerase and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular `nick-sensor' in vitro. Nu-cleic Acids Res. (1996) 24:4387–4394.
   PubMed Web of Science ®Google Scholar
• CHU G: Double strand break repair. J. Biol. Chem. (1997) 272 (39):24097–24100.
   PubMed Web of Science ®Google Scholar
• MODRICH P, LAHUE R: Mismatch repair in replication fidelity, genetic recombination and cancer biology. Ann. Rev. Biochem. (1996) 65:101–133.
   PubMed Web of Science ®Google Scholar
• LINDAHL T, KARR AN P, WOOD RD: DNA excision repair pathways. Curr. Opin. Genet. Dev. (1997) 7:158–169.
   PubMed Web of Science ®Google Scholar
• ••A critical review on the recent knowledge about excision re-pair mechanisms.
   Google Scholar
• KOLODNER RD: Mismatch repair. Mechanisms and re-lationship to cancer susceptibility. Trends Biochem. Sci. (1996) 20:397–401.
   Google Scholar
• BARRET JM, HILL BT: DNA repair mechanisms associ-ated with cellular resistance to antitumor drugs: po-tential novel targets. AntiCancer Drugs (1998) 9:105–123.
   PubMedGoogle Scholar
• ••A comprehensive review on the repair pathways and a dis-cussion of the cellular targets to overcome resistance to anti-tumour drugs.
   Google Scholar
• KARRAN P, HAMPSON R: Genomic instability and toler- ance to alkylating agents. Cancer Surveys (1996) 28:69–85.
   PubMedGoogle Scholar
• KARRAN P, BIGNAMI M: Drug-related killings: a case of mistaken identity. Chem. Biol. (1996) 3:875–879.
   PubMed Web of Science ®Google Scholar
• HILL BT: Drug resistance: an overview of the current state of the art. Int. J. Oncol. (1996) 9:197–203.
   PubMed Web of Science ®Google Scholar
• •A review aiming at the identification of the major intracellu-lar processes responsible for drug-resistance.
   Google Scholar
• LEHNERT M: Clinical multidrug resistance in cancer: a multifactorial problem. Eur. J. Cancer (1996) 32A:912–920.
   PubMed Web of Science ®Google Scholar
• ••A critical review on the complexity of the multi-drug resis-tance problems in cancer chemotherapy.
   Google Scholar
• LOWE SW, RULEY HE, JACKS T, HOUSMAN DE: P53-dependent apoptosis modulates cytotoxicity of anti-cancer agents. Cell (1993) 74:957–967.
   PubMed Web of Science ®Google Scholar
• HICKSON ID: General introduction to DNA base exci- sion repair. In: Base Excision Repair of DNA Damage. Hickson ID (Ed.), Springer, Landes Bioscience, Austin, Texas, USA (1997):1–5.
   Google Scholar
• •A good book stating the most recent knowledge about major excision repair pathways.
   Google Scholar
• KO c ON, PHILLIPS WP, LEE K et al.: Role of DNA repair in resistance to drugs that alkylate 06 of guanine. Drug Resist. (1996) 87:123–146.
   Google Scholar
• LUDLUM DB: The chloroethylnitrosoureas: sensitivity and resistance to cancer chemotherapy at the molecu-lar level. Cancer Invest. (1997) 15:588–598.
   PubMed Web of Science ®Google Scholar
• GERSON SL, WILLSON JKV: 06-Alkylguanine-DNA alkyl-transferase. A target for the modulation of drug resis-tance. Hematol. Oncol Clin. North Am. (1995) 9:431–450.
   PubMedGoogle Scholar
• PEGG AE, DOLAN ME, MOSCHEL RC: Structure, function, and inhibition of 06-alkylguanine-DNA alkyltransfe-rase. Prog. Nucleic Acid Res. Mol. Biol. (1995) 51:167–223.
   PubMed Web of Science ®Google Scholar
• •A good and complete review on what is known about AGT and its inhibition by small molecules.
   Google Scholar
• DOLAN ME, PEGG AE: 06-Benzylguanine and its role in chemotherapy. Clin. Cancer Res. (1997) 3(6) :837–847.
   PubMedGoogle Scholar
• PEGG AE, BOOSALIS M, SAMSON L et al: Mechanism of inactivation of human 06-alkylguanine-DNA alkyl-transferase by 06-benzylguanine. Biochemistry (1993) 32: 11998-12006.
   Google Scholar
• WEDGE SR, PORTEOUS JK, NEWLANDS ES 3 - Aminobenzamide and/or 06-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and 06- alkylguanine-DNA alkyltransferase activity. Br. J. Can-cer (1996) 74:1030–1036.
   PubMed Web of Science ®Google Scholar
• TENTORI L, ORLANDO L, LACAL PM et al.: Inhibition of06-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leuke-mic cells to apoptosis induced by temozolomide. Mol. Pharmacol. (1997) 52:249–258.
   PubMed Web of Science ®Google Scholar
• CHAE MY, SWENN K, KANUGULA S, DOLAN ME, PEGGAE, MOSCHEL RC: 8-Substituted 06-benzylguanine, sub-stituted 6(4)-(benzyloxy)pyrimidine, and related de-rivatives as inactivators of human 06-alkylguanine-DNA alkyltransferase. J. Med. Chem. (1995) 38:359–365.
   PubMedGoogle Scholar
• TERASHIMA I, KOHDA K: Inhibition of human 06-alkylguanine-DNA alkyltransferase and potentiation of the cytotoxicity of chloroethylnitrosourea by 4 (6)-(benzyloxy)-2,6(4)-diamino-5-(nitro or ni-troso)pyrimidine derivatives and analogues. J. Med. Chem. (1998) 41:503–508.
   PubMedGoogle Scholar
• MINEURA K, FUKUCHI M, KOWADA M, HITOMI K, TERASHIMA I, KOHDA K: Enhancement effect of 06-fluorobenzylguanines on chloroethylnitrosourea cytotoxicity in tumor cells. Life Sci. (1996) 58:303–308.
   Google Scholar
• CUSSAC C, RAPP M, MOUNETOU E et al: Enhancementby 06-benzyl-N-acetylguanosine derivatives of chloro-ethylnitrosourea antitumor action in chloroethylnitrosourea-resistant human malignant melanocytes. J. Pharmacol Exp. Ther. (1994) 271: 1353–1358.
   PubMedGoogle Scholar
• BUCHDAHL C, ROLHION C, GLASSER AL et al.:Melanoma-cell toxicity of cystemustine combined with 06-benzyl-N2-acetylguanosine. Melanoma Res. (1998) 8:123–130.
   PubMedGoogle Scholar
• CITTI L, BOLDRINI L, PREUSS I, KAINA B, MARIANI L, RAINALDI G: Targeting of 06-methylguanine-DNA methyltransferase (MGMT) activity by antimessenger oligonucleotide sensitizes CHO/Mex+ transfected cells to mitozolomide. Carcinogenesis (1996) 17(1)25–29.
   Google Scholar
• SATOH MS, LINDAHL T: Role of poly(ADP-ribose) for-mation in DNA repair. Nature (1992) 356:356–358.
   PubMed Web of Science ®Google Scholar
• ••A landmark paper in the field.
   Google Scholar
• SATOH MS, POIRIER GG, LINDAHL T: Dual function for poly(ADP-ribose) synthesis in response to DNA strand breakage. Biochemistry (1994) 33:7099–7106.
   PubMed Web of Science ®Google Scholar
• WANG ZQ, STINGL L, MORRISON C et al: PARP is impor-tant for genomic stability but dispensable in apopto-sis. Genes Devel. (1997) 11:2347–2358.
   PubMed Web of Science ®Google Scholar
• MENISSIER DE MURCIA J, NIEDERGANG C et al: Require-ment of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc. Natl. Acad. Sci. USA (1997) 8:7303–7307.
   Google Scholar
• LE RHUN Y, KIRKLAND JB, SHAH GM: Cellular responses to DNA damage in the absence of poly(ADP-ribose) po-lymerase. Biochem. Biophys. Res. Commun. (1998) 245:1–10.
   PubMed Web of Science ®Google Scholar
• OLSSON AR, SHENG Y, PERO RW, CHAPLIN DJ, HORSMANMR: DNA damage and repair in tumour and non- tumour tissues of mice induced by nicotinamide. Br. J. Cancer (1996) 74:368–373.
   PubMedGoogle Scholar
• ZHENG H, OLIVE PL: Reduction of tumor hypoxia and inhibition of DNA repair by nicotinamide after irradia-tion of SCCVII murine tumors and normal tissues. Can-cer Res. (1996) 56:2801–2808.
   PubMedGoogle Scholar
• ROJAS A, DENEKAMP HJ, KJELLEN E et al.: Nicotinamide as a repair inhibitor in vivo: studies using single and fractionated x-ray doses in mouse skin and kidneys. Radiation Res. (1996) 145:419–431.
   PubMedGoogle Scholar
• ZACKRISSON B, FRANZEN L, HENRIKSSON R et al. Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON). Acta Oncol. (1994) 33:377–381.
   PubMed Web of Science ®Google Scholar
• OGASAWARA H, NISHIO K, ISHIDA T, ARIOKA H, FU-KUOKA K, SAIJO N: In vitro enhancement of antitumor activity of a water-soluble duocarmycin derivative, KW-2189, by caffeine-mediated DNA-repair inhibition in human lung cancer cells. Jpn. J. Cancer Res. (1997) 88:1033–1037.
   PubMedGoogle Scholar
• MULLER WU, BAUCH T, WOJCIK A, BOCKER W, STREFFER C: Comet assay studies indicate that caffeine-mediated increase in radiation risk of embryos is due to inhibi-tion of DNA repair. Mutagenesis (1996) 11(0:57–60.
   PubMedGoogle Scholar
• TEMPEL K, VON ZALLINGER C: Caffeine-DNA interac-tions: biochemical investigations comprising DNA-repair enzymes and nucleic acid synthesis. Z. Natur-forsch. (1997) 52c:466–474.
   Google Scholar
• SCHILICKER A, PESCHKE P, BURKLE A, HAHN EW, KIM JH: 4-Amino-1,8-naphtalimide: a novel inhibitor of poly(ADP-ribose) polymearse and radiation sensi-tizer. Int. J. Radial Biol. (1999) 75:91–100.
   PubMedGoogle Scholar
• RUF A, DE MURCIA G, SCHULZ GE: Inhibitor and NAD binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling. Bio-chemistry (1998) 37:3893–3900.
   Google Scholar
• WATSON CY, WHISH WJ: Synthesis of 3-substituted ben-zamides and 5-substituted isoquinolin-1(211)- ones and preliminary evaluation as inhibitors of poly(ADP-ribose) polymerase (PARP). Bioorg. Med. Chem. (1998) 6:721–734.
   PubMedGoogle Scholar
• SHAH GM, POIRIER D, DESNOYERS S et al: Complete in-hibition of poly(ADP-ribose) polymerase activity pre-vents the recovery of C3H10T1/2 cells from oxidative stress. Biochimica Biophysica Acta (1996) 1312:1–7.
   PubMedGoogle Scholar
• GRIFFIN RJ, SRINIVASAN S, BOWMAN K et al.: Resistance-modifying agents-5-synthesis and biologi-cal properties of quinozolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase(PARP). Merl. Chem. (1998) 17:5247–5256.
   Google Scholar
• BOWMAN KJ, WHITE A, GOLDING BT, GRIFFIN RJ, CURTIN NJ: Potentiation of anti-cancer agent cytotoxic-ity by the potent poly(ADP-ribose) polymerase inhibi-tors NU1025 and NU1064. Br. J. Cancer (1998) 78:1269–1277.
   PubMed Web of Science ®Google Scholar
• HOFLACK JC, DURAND MJ, POIRIER GG, MAUL A, VAS-SEUR P: Alteration in methyl-methanesulfonate- induced poly(ADP-ribosy0 ation by 2-butoxyethanol in Syrian hamster embryo cells. Carcinogenesis (1997) 18(12)2333–2338.
   Google Scholar
• PERO RW, SHENG Y, OLSSON A, BRYNGELSSON C, LUND-PERO M: Hypochlorous acid/N-chloramines are naturally produced DNA repair inhibitors. Carcino-genesis (1996) 17(0:13–18.
   PubMedGoogle Scholar
• OKAYASU R, SUETOMI K, ULLRICH RL: Wortmannin in-hibits repair of DNA double-strand breaks in irradi-ated normal human cells. Radiation Res. (1998) 149:440–445.
   PubMedGoogle Scholar
• BOULTON S, KYLE S, YALCINTEPE L, DURKACZ BW: Wortmannin is a potent inhibitor of DNA double strand break but not single strand break repair in Chi-nese hamster ovary cells. Carcinogenesis (1996) 17:2285–2290.
   PubMedGoogle Scholar
• TUTEJA N, PHAN TN, TUTEJA R, OCHEM A, FALACHI A: In-hibition of unwinding and ATPase activity of human DNA helicase II by chemotherapeutic agents. Biochem. Biophys. Res. Commun. (1997) 263:636–640.
   Google Scholar
• SARGENT JM, ELGIE AW, WILLIAMSON CJ, TAYLOR CG: Aphidicolin markedly increases the platinum sensitiv-ity of cells from primary ovarian tumours. Br. J. Cancer (1996) 74:1730–1733.
   PubMed Web of Science ®Google Scholar
• O'DWYER PJ, MOYER JD, SUFFNESS M et al: Antitumor activity and biochemical effects of aphidicolin glyci-nate (NSC 303812) alone and in combination with cis-platin in vivo. Cancer Res. (1994) 54(3):724–729.
   PubMedGoogle Scholar
• BERGMAN AM, RUIZ VAN HAPEREN VINT, VEERMAN G, KUIPER CM, PETERS GJ: Synergistic interaction between cisplatin and gemcitabine in vitro. Clin. Cancer Res. (1996) 2:521–530.
   PubMed Web of Science ®Google Scholar
• LORUSSO V, POLLERA CF, ANTIMI M et al: A Phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Can-cer. Eur. J. Cancer. (1998) 34 (8) :1208–1212.
   PubMed Web of Science ®Google Scholar
• LANGER CJ, OZOLS RF: Gemcitabine and carboplatin in combination: Phase I and Phase II studies. Semin. On-col. (1998) 25(4 Suppl. 9):51–54.
   Google Scholar
• SANDOVAL A, CONSOLI U, PLUNKETT W: Fluradabine-mediated inhibition of nucleotide excision repair in-duces apoptosis in quiescent human lymphocytes. Clin. Cancer Res. (1996) 2:1731–1741.
   PubMed Web of Science ®Google Scholar
• LI L, LIU X, GLASSMAN AB et al.: Fludarabine triphos-phate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro. Cancer Res. (1997) 57:1487–1494.
   PubMed Web of Science ®Google Scholar
• FKYERAT A, DEMEUNYNCK M, CONSTANT JF, MICHON P,LHOMME J: A new class of artificial nucleases that rec-ognize and cleave apurinic sites in DNA with great se-lectivity and efficiency. J. Am. Chem. Soc. (1993) 115:9952–9959.
   Web of Science ®Google Scholar
• BERTHET N, BOUDALI A, CONSTANT JF et al.: Design ofmolecules that specifically recognize and cleave apurinic sites in DNA. J. Mol. Recognit. (1994) 7:99–107.
   PubMedGoogle Scholar
• BERTHET N, CONSTANT JF, DEMEUNYNCK M, MICHON P, LHOMME J: Search for DNA repair inhibitors: selec-tive binding of nucleic bases-acridine conjugates to a DNA duplex containing an abasic site. J. Med. Chem. (1997) 40:3346–3352.
   PubMedGoogle Scholar
• COPPEL Y, CONSTANT JF, COULOMBEAU C, DEME-UNYNCK M, GARCIA J, LHOMME J: NMR and molecular modeling studies of the interaction of artificial AP ly-ases with a DNA duplex containing an apurinic abasic site model. Biochemistry (1997) 36:4831–4843.
   PubMedGoogle Scholar
• BARRET JM, FAHY J, ETIEVANT C, LHOMME J, HILL BT: Novel artificial endonucleases inhibit base excision re-pair and potentiate the cytotoxicity of DNA-damaging agents on L1210 cells. AntiCancer Drugs (1999) 10:55–65.
   PubMedGoogle Scholar
• GRAFSTROM RH, SUN T, DOLENIAK D: AP endonuclease: a possible target for a novel tumoricidal compound [meeting abstract]. J. Cell. Biochem. (1995) Suppl. 21A:279.
   Google Scholar
• BOBOLA MS, BERGER MS, STEVENS B, SILBER JR: Varia-tion of DMP 840 resistance and relationship to apurinic/apyrimidic endonuclease activity and alky-lating agent sensitivity in 12 brain tumor cell lines. Proc. Am. Assoc. Cancer Res. (1997) 38:314.
   Google Scholar
• HARTMANN A, SPEIT G: Effect of arsenic and cadmium on the persistence of mutagen-induced DNA lesions in human cells. Environ. Mol Mutagenesis (1996) 27:98–104.
   PubMed Web of Science ®Google Scholar
• HARTWIG A, SCHLEPEGRELL R, DALLY H, HARTMANN M: Interaction of carcinogenic metal compounds with de-oxyribonucleic acid repair processes. Ann. Clin. Lab. Sci. (1996) 26:31.
   PubMedGoogle Scholar
• CHAO CCK: Inhibition by arsenite of anticancer drug cis-diamminedichloroplatinium(I0 induced DNA re-pair and drug resistance in HeLa cells. Environm. Toxi-col. Pharmacol. (1996):199–205.
   Google Scholar
• WEI YF, CHEN BJ, SAMSON L: Suppression of Escheri-chia coli alkB mutants by Saccharomyces cerevisiae genes. J. Bacteriol (1995) 177:5009–5015.
   PubMedGoogle Scholar